Clinical Trial Update: Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for certolizumab pegol in active rheumatoid arthritis; results posted following completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Certolizumab pegol (certolizumab pegol)

Snippet

Sponsor: UCB Pharma | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2011-05-06